In vitro expression of 34 naturally occurring mutant variants of phenylalanine hydroxylase: correlation with metabolic phenotypes and susceptibility toward protein aggregation
- PMID: 11161839
- DOI: 10.1006/mgme.2000.3118
In vitro expression of 34 naturally occurring mutant variants of phenylalanine hydroxylase: correlation with metabolic phenotypes and susceptibility toward protein aggregation
Abstract
Phenylalanine hydroxylase (PAH) is a homotetrameric enzyme that catalyzes the conversion of phenylalanine to tyrosine, the rate-limiting step of phenylalanine disposal in humans. Primary dysfunction of PAH caused by mutations in the PAH gene results in hyperphenylalaninemia, which may impair cognitive development unless corrected by dietary restriction of phenylalanine. The mechanism(s) by which PAH missense mutations cause enzyme impairment has been studied in detail only in a small number of cases, but existing evidence points to a major role of enhanced proteolytic degradation due to aberrant folding of mutant polypeptides. We have used two heterologous in vitro expression systems (a mammalian cell-free transcription-translation system and the pET system of Escherichia coli) to examine 34 mutations that have been associated with PAH deficiency in the Danish population. These mutations represent a broad range of amino acid substitutions, functional enzyme domains, and metabolic phenotypes. In both systems, residual in vitro activities correlated broadly with metabolic phenotypes, however, with significant discrepancies. Analysis of E. coli extracts by nondenaturing polyacrylamide gel electrophoresis and storage experiments showed that (i) in general, mutations in the N-terminal regulatory domain are associated with relatively stable proteins compared to most mutations in the central catalytic domain, and (ii) for mutations in the catalytic domain, high levels of protein aggregation do not always correspond with a severe phenotype. Our data support and extend previous evidence that PAH mutations exert their pathogenic effects by several distinct mechanisms that may operate individually or in concert.
Copyright 2001 Academic Press.
Similar articles
-
Alterations in protein aggregation and degradation due to mild and severe missense mutations (A104D, R157N) in the human phenylalanine hydroxylase gene (PAH).Hum Mutat. 1998;12(5):344-54. doi: 10.1002/(SICI)1098-1004(1998)12:5<344::AID-HUMU8>3.0.CO;2-D. Hum Mutat. 1998. PMID: 9792411
-
Structural interpretation of mutations in phenylalanine hydroxylase protein aids in identifying genotype-phenotype correlations in phenylketonuria.Eur J Hum Genet. 2000 Sep;8(9):683-96. doi: 10.1038/sj.ejhg.5200518. Eur J Hum Genet. 2000. PMID: 10980574
-
Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH.Hum Mutat. 2003 Apr;21(4):370-8. doi: 10.1002/humu.10198. Hum Mutat. 2003. PMID: 12655546
-
How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression.Hum Mutat. 2003 Apr;21(4):357-69. doi: 10.1002/humu.10197. Hum Mutat. 2003. PMID: 12655545 Review.
-
In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function.Hum Mutat. 1998;11(1):4-17. doi: 10.1002/(SICI)1098-1004(1998)11:1<4::AID-HUMU2>3.0.CO;2-L. Hum Mutat. 1998. PMID: 9450897 Review.
Cited by
-
Folding dynamics of phenylalanine hydroxylase depends on the enzyme's metallation state: the native metal, iron, protects against aggregate intermediates.Eur Biophys J. 2011 Aug;40(8):959-68. doi: 10.1007/s00249-011-0711-6. Epub 2011 Jun 7. Eur Biophys J. 2011. PMID: 21647679
-
Genotype-phenotype correlations and BH4 estimated responsiveness in patients with phenylketonuria from Rio de Janeiro, Southeast Brazil.Mol Genet Genomic Med. 2019 May;7(5):e610. doi: 10.1002/mgg3.610. Epub 2019 Mar 3. Mol Genet Genomic Med. 2019. PMID: 30829006 Free PMC article.
-
The Pah-R261Q mouse reveals oxidative stress associated with amyloid-like hepatic aggregation of mutant phenylalanine hydroxylase.Nat Commun. 2021 Apr 6;12(1):2073. doi: 10.1038/s41467-021-22107-1. Nat Commun. 2021. PMID: 33824313 Free PMC article.
-
Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation.J Inherit Metab Dis. 2010 Feb;33(1):9-16. doi: 10.1007/s10545-009-9002-0. J Inherit Metab Dis. 2010. PMID: 20063067
-
Molecular characterization of Thai patients with phenylalanine hydroxylase deficiency and in vitro functional study of two novel PAH variants.Mol Biol Rep. 2021 Mar;48(3):2063-2070. doi: 10.1007/s11033-021-06163-w. Epub 2021 Mar 7. Mol Biol Rep. 2021. PMID: 33677757
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources